Document is current
Any future updates will be listed below
-
Authors
Armenti, Mirco https://orcid.org/0009-0002-9203-7507
Maioli, Sara https://orcid.org/0009-0006-2513-3098
Riva, Chiara https://orcid.org/0009-0007-9393-9672
Currò, Nicola https://orcid.org/0000-0002-6802-0126
Moschetti, Giorgia https://orcid.org/0000-0001-7763-4421
Salvi, Mario https://orcid.org/0000-0002-0276-0367
Muller, Ilaria https://orcid.org/0000-0003-2926-0722
-
Funding
Funding for this research was provided by:
Society for Endocrinology
European Thyroid Association
Ministero dell'Università e della Ricerca
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 3 December 2025
First Online: 27 December 2025
Declarations
:
: This study was approved by the ethical committee of Milano Area 2 (permission 0004946 69_2020bis 7/2/2020 ID 1333).
: Written informed consent was obtained from the patient for the publication of this case report.
: I.M. is an Associate Editor of the Journal and the Guest Editor of this Collection; she was not involved in handling this manuscript during the manuscript review process. She received consulting fees from Alexion Pharma, Amgen, Merck, Tourmaline, Argenx and Lundbeck. M.S. received consulting fees from IBSA, Argenx, Third Rock Ventures, Tourmaline, Immunovant, Lycia, Amgen, Viridian, Merck. M.A., S.M., C.R., G.M., N.C. have no disclosures to declare.
